THERESA NEFF: Open Payments
NPI 1194810317 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,831 in 83 payments from 19 companies in 2025. Trend: 2023 $1,021 · 2024 $1,355 · 2025 $1,831
Food & beverage: $1,831
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $476 |
| AstraZeneca Pharmaceuticals LP | 15 | $390 |
| GlaxoSmithKline, LLC. | 9 | $157 |
| Amgen Inc. | 8 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $112 |
| Lilly USA, LLC | 4 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| Almatica Pharma LLC | 3 | $53 |
| PFIZER INC. | 2 | $44 |
Products named: AIRSUPRA, Wegovy, TRELEGY ELLIPTA, JARDIANCE, Rybelsus, REXULTI, EVENITY, CAPLYTA.
Industry payments across PA — which companies pay providers there.
